Adropin was demonstrated to play an essential role in activating downstream insulin signaling, maintaining glucose homeostasis and lipid metabolism, and guarding against obesity-related hyperinsulinemia and hepatic steatosis [9,10,11,12]. The gene discussed is ENHO; the disease is obesity disorder.